Dr Luis Nieves, MD | |
1717 Precinct Line Rd Ste 204, Hurst, TX 76054-3169 | |
(855) 549-7246 | |
(817) 514-1901 |
Full Name | Dr Luis Nieves |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 26 Years |
Location | 1717 Precinct Line Rd Ste 204, Hurst, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801089503 | NPI | - | NPPES |
196884602 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207QS0010X | Family Medicine - Sports Medicine | M7476 (Texas) | Secondary |
208VP0014X | Pain Medicine - Interventional Pain Medicine | M7476 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Texas Pain Relief Group Pllc | 2668603952 | 23 |
News Archive
Diabetics living in the UK worry about disruption to insulin supplies as a result of Brexit, new research shows.
As if straight out of a Monty Python sketch, New Zealand's Health and Disability Commission has issued final opinion on a women who had all of her bottom teeth removed by accident.
Researchers at the Yerkes National Primate Research Center, Emory University, have shown inducing the release of brain oxytocin may be a viable therapeutic option for enhancing social function in psychiatric disorders, including autism spectrum disorders and schizophrenia.
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that enrollment of its X-22 Phase II-B clinical trial has been successfully completed; 234 smokers have been randomized in the double-blind, active-controlled, multi-center smoking cessation study.
IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.
› Verified 8 days ago
Entity Name | Texas Pain Relief Group Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003246299 PECOS PAC ID: 2668603952 Enrollment ID: O20140331000940 |
News Archive
Diabetics living in the UK worry about disruption to insulin supplies as a result of Brexit, new research shows.
As if straight out of a Monty Python sketch, New Zealand's Health and Disability Commission has issued final opinion on a women who had all of her bottom teeth removed by accident.
Researchers at the Yerkes National Primate Research Center, Emory University, have shown inducing the release of brain oxytocin may be a viable therapeutic option for enhancing social function in psychiatric disorders, including autism spectrum disorders and schizophrenia.
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that enrollment of its X-22 Phase II-B clinical trial has been successfully completed; 234 smokers have been randomized in the double-blind, active-controlled, multi-center smoking cessation study.
IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Luis Nieves, MD 4730 N Habana Ave, Ste 204, Tampa, FL 33614-7163 Ph: (813) 549-2134 | Dr Luis Nieves, MD 1717 Precinct Line Rd Ste 204, Hurst, TX 76054-3169 Ph: (855) 549-7246 |
News Archive
Diabetics living in the UK worry about disruption to insulin supplies as a result of Brexit, new research shows.
As if straight out of a Monty Python sketch, New Zealand's Health and Disability Commission has issued final opinion on a women who had all of her bottom teeth removed by accident.
Researchers at the Yerkes National Primate Research Center, Emory University, have shown inducing the release of brain oxytocin may be a viable therapeutic option for enhancing social function in psychiatric disorders, including autism spectrum disorders and schizophrenia.
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that enrollment of its X-22 Phase II-B clinical trial has been successfully completed; 234 smokers have been randomized in the double-blind, active-controlled, multi-center smoking cessation study.
IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.
› Verified 8 days ago